Screening of an FDA-approved drug library reveals MEK1/2 inhibitors block production of osteoarthritis mediators in activated human chondrocytes and synovial fibroblasts.

Bibliographic Details
Published in:Osteoarthritis & Cartilage Vol. 34; no. 6; pp. 806 - 819
Main Authors: Coryell, Philip R., Fernandez Davila, Jorge G., Yanke, Adam B., Pearce, Kenneth H., Loeser, Richard F.
Format: Journal Article
Published: Elsevier B.V. Jun2026
Online Access:View this record in EBSCOhost